How much revenue does Stem make?

Stem reported $0 in revenue for fiscal year 2023.

What companies are similar to Stem?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Eureka 93 Inc. (LXLLF), Notable Labs, Ltd. (NTBLQ), Cardax, Inc. (CDXI), OncoSec Medical Incorporated (ONCSQ).

Stem Holdings, Inc. (STMH) Stock

About Stem Holdings, Inc.

Stem Holdings, Inc. does not have significant operations. Previously, the company operated as a vertically-integrated cannabis products and technology company. Its brands include TJ's Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavor edible confections; and e-commerce delivery platforms provided direct-to consumer proprietary logistics and an omnichannel UX (user experience)/CX ...

At a glance

Stem reported revenue of $0 for fiscal year 2023, and net income of -$19.02 million.

Figures from company filings; latest fiscal year ended September 30, 2023.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.